RPSAP74

Across TCGA pan-cancer cohorts, RPSAP74 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPSAP74 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RPSAP74 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPSAP74 expression acts as an unfavorable survival marker, although some lineages such as KIRC and BLCA show a favorable association.

STAD, KIRC, and LIHC are the cancer types where RPSAP74 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Median	II,III,IV	0.459	0.602	.003	62	view →
KIRC	DFS	Tertile	III,IV	0.585	0.414	.014	30	view →
LIHC	DFS	Tertile	III,IV	0.256	0.468	.016	27	view →
ACC	DFS	Quartile	II,III,IV	0.078	0.452	.024	26	view →
BLCA	DFS	Median	IV	0.617	0.245	.006	25	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
LUAD	OS	Quartile	All	0.533	0.720	.002	16	view →
SKCM	OS	Median	II,III,IV	0.255	0.456	<.001	14	view →
COAD	DFS	Quartile	IV	0.193	0.539	.006	13	view →
HNSC	DFS	Quartile	IV	0.512	0.310	.026	12	view →
LUSC	DFS	Tertile	III,IV	0.400	0.805	.017	9	view →
KIRP	DFS	Quartile	IV	0.264	0.805	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPSAP74–STAD (DFS)

Open the STAD breakdown →